Thread
:
(MUC1 agonist to reverse multiple resistances) MUC1* is a determinant of trastuzumab
View Single Post
05-07-2009, 06:20 AM
#
4
Hopeful
Senior Member
Join Date: Aug 2006
Posts: 3,380
?
"Of the 42,000 breast cancer patients who overexpress the HER2 growth factor receptor, <35% are responsive to treatment with the HER2-disabling antibody, called trastuzumab (Herceptin)."
I'd like to see how they arrived at this stat.
Hopeful
Hopeful
View Public Profile
Send a private message to Hopeful
Find More Posts by Hopeful